These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2178354)

  • 41. Poliovirus tropism and attenuation are determined after internal ribosome entry.
    Kauder SE; Racaniello VR
    J Clin Invest; 2004 Jun; 113(12):1743-53. PubMed ID: 15199409
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of a rare natural intertypic type 2/type 3 penta-recombinant vaccine-derived poliovirus isolated from a child with acute flaccid paralysis.
    Zhang Y; Wang H; Zhu S; Li Y; Song L; Liu Y; Liu G; Nishimura Y; Chen L; Yan D; Wang D; An H; Shimizu H; Xu A; Xu W
    J Gen Virol; 2010 Feb; 91(Pt 2):421-9. PubMed ID: 19846676
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PCR assays for the identification of rare recombination types from VP1 to 3D genomic region of vaccine derived poliovirus strains.
    Dimitriou TG; Pliaka V; Kyriakopoulou Z; Ruether IG; Tsakogiannis D; Fountoucidou P; Gartzonika C; Levidiotou-Stefanou S; Markoulatos P
    Mol Cell Probes; 2014 Aug; 28(4):107-12. PubMed ID: 24315968
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An Introduction to Poliovirus: Pathogenesis, Vaccination, and the Endgame for Global Eradication.
    Minor PD
    Methods Mol Biol; 2016; 1387():1-10. PubMed ID: 26983727
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The molecular biology of poliovaccines.
    Minor PD
    J Gen Virol; 1992 Dec; 73 ( Pt 12)():3065-77. PubMed ID: 1335021
    [No Abstract]   [Full Text] [Related]  

  • 46. Polio vaccines and the cessation of vaccination.
    Minor PD
    Expert Rev Vaccines; 2003 Feb; 2(1):99-104. PubMed ID: 12901601
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence of vaccine-derived polioviruses in stools of immunodeficient children in South Africa.
    Pavlov DN; Van Zyl WB; Van Heerden J; Kruger M; Blignaut L; Grabow WO; Ehlers MM
    J Appl Microbiol; 2006 Dec; 101(6):1367-79. PubMed ID: 17105568
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Methods to Monitor Molecular Consistency of Oral Polio Vaccine.
    Chumakov KM
    Methods Mol Biol; 2016; 1387():263-77. PubMed ID: 26983740
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Microevolution of type 3 Sabin strain of poliovirus in cell cultures and its implications for oral poliovirus vaccine quality control.
    Rezapkin GV; Norwood LP; Taffs RE; Dragunsky EM; Levenbook IS; Chumakov KM
    Virology; 1995 Aug; 211(2):377-84. PubMed ID: 7645242
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Laboratory tests for live attenuated poliovirus vaccines.
    Wood DJ; Macadam AJ
    Biologicals; 1997 Mar; 25(1):3-15. PubMed ID: 9167004
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The 5' noncoding region and virulence of poliovirus vaccine strains.
    Macadam AJ; Stone DM; Almond JW; Minor PD
    Trends Microbiol; 1994 Nov; 2(11):449-54. PubMed ID: 7866703
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Poliovirus biology.
    Minor PD
    Structure; 1996 Jul; 4(7):775-8. PubMed ID: 8805561
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification and manipulation of the molecular determinants influencing poliovirus recombination.
    Runckel C; Westesson O; Andino R; DeRisi JL
    PLoS Pathog; 2013 Feb; 9(2):e1003164. PubMed ID: 23408891
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transformation and Tumorigenicity Testing of Simian Cell Lines and Evaluation of Poliovirus Replication.
    Dotti S; Lombardo T; Villa R; Cacciamali A; Zanotti C; Andreani NA; Cinotti S; Ferrari M
    PLoS One; 2017; 12(1):e0169391. PubMed ID: 28046048
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ADAR Editing in Viruses: An Evolutionary Force to Reckon with.
    Piontkivska H; Wales-McGrath B; Miyamoto M; Wayne ML
    Genome Biol Evol; 2021 Nov; 13(11):. PubMed ID: 34694399
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vaccination of adults against travel-related infectious diseases, and new developments in vaccines.
    Döller PC
    Infection; 1993; 21(1):1-17. PubMed ID: 8449574
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Picornavirus inhibitors.
    Carrasco L
    Pharmacol Ther; 1994; 64(2):215-90. PubMed ID: 7533301
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of mutations G-480 and C-6203 in the attenuation phenotype of Sabin type 1 poliovirus.
    McGoldrick A; Macadam AJ; Dunn G; Rowe A; Burlison J; Minor PD; Meredith J; Evans DJ; Almond JW
    J Virol; 1995 Dec; 69(12):7601-5. PubMed ID: 7494267
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular biology and the control of viral vaccines.
    Minor PD; Macadam A; Cammack N; Dunn G; Almond JW
    FEMS Microbiol Immunol; 1990 Nov; 2(4):207-13. PubMed ID: 2178354
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Isolation of recombinant vaccine strains of poliovirus from patients with poliomyelitis].
    Kutitova OK; Lipskaia GIu; Maslova SV; Agol VI
    Mol Gen Mikrobiol Virusol; 1989 Nov; (11):14-20. PubMed ID: 2560812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.